首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Minimal Risk in Pediatric Research: A Philosophical Review and Reconsideration
Authors:John Rossi  Robert M Nelson
Institution:1. Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA;2. Office of Pediatric Therapeutics (OPT), Office of the Commissioner (OC), United States Food and Drug Administration (FDA), Silver Spring, Maryland, USA
Abstract:Despite more than thirty years of debate, disagreement persists among research ethicists about the most appropriate way to interpret the U.S. regulations on pediatric research, specifically the categories of “minimal risk” and a “minor increase over minimal risk.” Focusing primarily on the definition of “minimal risk,” we argue in this article that the continued debate about the pediatric risk categories is at least partly because their conceptual status is seldom considered directly. Once this is done, it becomes clear that the most popular strategy for interpreting “minimal risk”—defining it as a specific set of risks—is indefensible and, from a pragmatic perspective, unlikely to resolve disagreement. Primarily this is because judgments about minimal risk are both normative and heavily intuitive in nature and thus cannot easily be captured by reductions to a given set of risks. We suggest instead that a more defensible approach to evaluating risk should incorporate room for reflection and deliberation. This dispositional, deliberative framework can nonetheless accommodate a number of intellectual resources for reducing reliance on sheer intuition and improving the quality of risk evaluations.
Keywords:Ethics and public policy  history of research ethics  human subjects ethics  human subjects regulation and oversight  pediatric research ethics  research ethics
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号